bluebird bio unveils positive, albeit early, data for gene therapy – BioPharma Dive
|
bluebird bio unveils positive, albeit early, data for gene therapy
BioPharma Dive Published in the New England Journal of Medicine, the study results showed bluebird bio's hematopoietic stem-cell gene therapy met the primary endpoint, with 15 of the 17 patients (or 88%) receiving the therapy free of major functional disabilities … |
